Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Apr;10(4):231-9.
doi: 10.1097/GIM.0b013e31816b64dc.

Genetic aspects of Alzheimer disease

Affiliations
Review

Genetic aspects of Alzheimer disease

Thomas D Bird. Genet Med. 2008 Apr.

Abstract

Alzheimer disease is the most common cause of dementia and represents a major public health problem. The neuropathologic findings of amyloid-beta plaques and tau containing neurofibrillary tangles represent important molecular clues to the underlying pathogenesis. Genetic factors are well recognized, but complicated. Three rare forms of autosomal-dominant early-onset familial Alzheimer disease have been identified and are associated with mutations in amyloid precursor protein, presenilin 1, and presenilin 2 genes. The more common late-onset form of Alzheimer disease is assumed to be polygenic/multifactorial. However, thus far the only clearly identified genetic risk factor for Alzheimer disease is Apo lipoprotein E. The epsilon4 allele of Apo lipoprotein E influences age at onset of Alzheimer disease, but is neither necessary nor sufficient for the disease. The search continues for the discovery of additional genetic influences.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Normal adult brain (top) compared with Alzheimer brain (bottom) showing marked diffuse cortical atrophy and ventricular enlargement.
Figure 2
Figure 2
Microscopic neuropathology of Alzheimer’s disease showing a neuritic plaque (lower left hand corner) and neurofibrillary tangles (upper right hand corner).
Figure 3
Figure 3
Molecular Aspects of the APP gene and protein showing the sites of cleavage by α, β and γ; secretases, production of the Aβ peptide (upper right) and sites of several disease causing mutations (bottom line).

References

Literature Cited

    1. Bird TD, Miller BL. Alzheimer’s disease and primary dementias. In: Kasper D, Fauci A, Branwald E, et al., editors. Harrison’s Principles of Internal Medicine. 16 ed. McGraw-Hill; NY: 2005. pp. 2393–406.
    1. Mayeux R, Saunders AM, Shea S, Mirra S, et al. Alzheimer’s Disease Centers Consortium on Apolipoprotein E and Alzheimer’s Disease Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. N Engl J Med. 1998;338:506–11. - PubMed
    1. Kaye JA. Diagnostic challenges in dementia. Neurology. 1998;51:45–52. - PubMed
    1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239–59. - PubMed
    1. National Institute on Aging-Reagan Working Group Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. Neurobiol Aging. 1997;18(Suppl 4):S1–2. - PubMed

References

    1. American College of Medical Genetics. American Society of Human Genetics Working Group on ApoE and Alzheimer’s disease . Statement on use of apolipoprotein E testing for Alzheimer’s disease. 1995. - PubMed
    1. American Society of Human Genetics and American College of Medical Genetics . Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. 1995. - PMC - PubMed
    1. National Institute on Aging. Alzheimer’s Association Working Group Apolipoprotein E genotyping in Alzheimer’s disease. Lancet. 1996;347:1091–5. - PubMed
    1. National Society of Genetic Counselors . Resolution on prenatal and childhood testing for adult-onset disorders. 1995.
    1. Post SG, Whitehouse PJ, Binstock RH, Bird TD, Eckert SK, Farrer LA, Fleck LM, Gaines AD, Juengst ET, Karlinsky H, Miles S, Murray TH, Quaid KA, Relkin NR, Roses AD, St George-Hyslop PH, Sachs GA, Steinbock B, Truschke EF, Zinn AB. The clinical introduction of genetic testing for Alzheimer’s disease: an ethical perspective. JAMA. 1997;277:832–6. - PubMed

Publication types